These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21495676)

  • 1. Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI.
    Bennewitz MF; Lobo TL; Nkansah MK; Ulas G; Brudvig GW; Shapiro EM
    ACS Nano; 2011 May; 5(5):3438-46. PubMed ID: 21495676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically viable magnetic poly(lactide-co-glycolide) particles for MRI-based cell tracking.
    Granot D; Nkansah MK; Bennewitz MF; Tang KS; Markakis EA; Shapiro EM
    Magn Reson Med; 2014 Mar; 71(3):1238-50. PubMed ID: 23568825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic poly(lactide-co-glycolide) and cellulose particles for MRI-based cell tracking.
    Nkansah MK; Thakral D; Shapiro EM
    Magn Reson Med; 2011 Jun; 65(6):1776-85. PubMed ID: 21404328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(lactic-co-glycolic acid) encapsulated gadolinium oxide nanoparticles for MRI-based cell tracking.
    Bennewitz MF; Williams SS; Nkansah MK; Shapiro EM
    J Nanosci Nanotechnol; 2013 Jun; 13(6):3778-83. PubMed ID: 23862407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-modality, fluorescent, PLGA encapsulated bismuth nanoparticles for molecular and cellular fluorescence imaging and computed tomography.
    Swy ER; Schwartz-Duval AS; Shuboni DD; Latourette MT; Mallet CL; Parys M; Cormode DP; Shapiro EM
    Nanoscale; 2014 Nov; 6(21):13104-12. PubMed ID: 25248645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of cryoprotection on the use of PLGA encapsulated iron oxide nanoparticles for magnetic cell labeling.
    Tang KS; Hashmi SM; Shapiro EM
    Nanotechnology; 2013 Mar; 24(12):125101. PubMed ID: 23459030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents.
    Doiron AL; Homan KA; Emelianov S; Brannon-Peppas L
    Pharm Res; 2009 Mar; 26(3):674-82. PubMed ID: 19034628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of silica coated MnO nanoparticles to control MRI relaxivity in response to specific physiological changes.
    Lee YC; Chen DY; Dodd SJ; Bouraoud N; Koretsky AP; Krishnan KM
    Biomaterials; 2012 May; 33(13):3560-7. PubMed ID: 22341582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
    Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
    J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and optimization of doxorubicin loaded poly(lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells.
    Deng L; Li L; Yang H; Li L; Zhao F; Wu C; Liu Y
    J Nanosci Nanotechnol; 2014 Apr; 14(4):2947-54. PubMed ID: 24734715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems.
    Schwendeman SP
    Crit Rev Ther Drug Carrier Syst; 2002; 19(1):73-98. PubMed ID: 12046892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved double emulsion technology for fabricating autofluorescent microcapsules as novel ultrasonic/fluorescent dual-modality contrast agents.
    Gong A; Ma X; Xiang L; Ren W; Shen Z; Wu A
    Colloids Surf B Biointerfaces; 2014 Apr; 116():561-7. PubMed ID: 24583258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of PLGA based nanoparticles for imaging guided applications.
    Mariano RN; Alberti D; Cutrin JC; Geninatti Crich S; Aime S
    Mol Pharm; 2014 Nov; 11(11):4100-6. PubMed ID: 25225751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuning the size and composition of manganese oxide nanoparticles through varying temperature ramp and aging time.
    Martinez de la Torre C; Grossman JH; Bobko AA; Bennewitz MF
    PLoS One; 2020; 15(9):e0239034. PubMed ID: 32946514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical detection of indocyanine green encapsulated biocompatible poly (lactic-co-glycolic) acid nanoparticles with photothermal optical coherence tomography.
    Subhash HM; Xie H; Smith JW; McCarty OJ
    Opt Lett; 2012 Mar; 37(5):981-3. PubMed ID: 22378459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveat Emptor: Commercialized Manganese Oxide Nanoparticles Exhibit Unintended Properties.
    Martinez de la Torre C; Freshwater KA; Looney-Sanders MA; Wang Q; Bennewitz MF
    ACS Omega; 2023 May; 8(21):18799-18810. PubMed ID: 37273625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid oligomers: Part II. Biodegradation and drug delivery application.
    Wang N; Wu XS
    J Biomater Sci Polym Ed; 1997; 9(1):75-87. PubMed ID: 9505204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porcine insulin biodegradable polyester microspheres: stability and in vitro release characteristics.
    Shao PG; Bailey LC
    Pharm Dev Technol; 2000; 5(1):1-9. PubMed ID: 10669912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diazeniumdiolate-doped poly(lactic-co-glycolic acid)-based nitric oxide releasing films as antibiofilm coatings.
    Cai W; Wu J; Xi C; Meyerhoff ME
    Biomaterials; 2012 Nov; 33(32):7933-44. PubMed ID: 22841918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres.
    Fu K; Pack DW; Klibanov AM; Langer R
    Pharm Res; 2000 Jan; 17(1):100-6. PubMed ID: 10714616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.